<DOC>
	<DOCNO>NCT01925755</DOCNO>
	<brief_summary>This local prospective multicenter observational non-interventional local study . Primary study objective investigate describe prescription pattern neurologist secondary stroke non-CNS ( non-Central Nervous System ) systemic embolism prevention patient AF ( Atrial fibrillation ) prior stroke TIA ( Transient Ischemic attack ) treat rivaroxaban initial visit three follow-up visit .</brief_summary>
	<brief_title>Non-interventional Local Study Prescription Behavior Anticoagulation Therapy Secondary Stroke Prevention Atrial Fibrillation Patients</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<criteria>Male female patient ≥ 18 year old start treatment rivaroxaban Nonvalvular Atrial Fibrillation document patient ' file Prior TIA/Stroke history TIA 72 hour document TIA 2 week nonhemorrhagic stroke Written inform consent Contraindications use Xarelto® accordance approve product label Previous thromboprophylaxis treatment anticoagulant prior toby reason stroke / TIA prevention Any reason medical nonmedical character , opinion physician hamper patient participation NIS</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Non-interventional</keyword>
	<keyword>Rivaroxaban</keyword>
	<keyword>Prevention prior stroke TIA</keyword>
	<keyword>Russian Federation</keyword>
</DOC>